Insider Transactions in Q3 2024 at Seres Therapeutics, Inc. (MCRB)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2024
|
Lisa Von Moltke |
SELL
Open market or private sale
|
Direct |
973
-4.43%
|
$0
$0.84 P/Share
|
|
Aug 16
2024
|
Thomas Des Rosier Chief Legal Officer and EVP |
SELL
Open market or private sale
|
Direct |
873
-0.7%
|
$0
$0.84 P/Share
|
|
Aug 16
2024
|
Matthew R. Henn |
SELL
Open market or private sale
|
Direct |
923
-1.35%
|
$0
$0.84 P/Share
|
|
Aug 16
2024
|
Teresa L. Young |
SELL
Open market or private sale
|
Direct |
728
-0.9%
|
$0
$0.84 P/Share
|
|
Aug 16
2024
|
Eric D. Shaff CEO and President |
SELL
Open market or private sale
|
Direct |
2,518
-1.7%
|
$0
$0.84 P/Share
|
|
Aug 16
2024
|
David S. Ege |
SELL
Open market or private sale
|
Direct |
1,128
-1.43%
|
$0
$0.84 P/Share
|
|
Aug 15
2024
|
Lisa Von Moltke |
BUY
Exercise of conversion of derivative security
|
Direct |
2,969
+11.9%
|
-
|
|
Aug 15
2024
|
Thomas Des Rosier Chief Legal Officer and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
2,656
+2.08%
|
-
|
|
Aug 15
2024
|
Matthew R. Henn |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+3.96%
|
-
|
|
Aug 15
2024
|
Teresa L. Young |
BUY
Exercise of conversion of derivative security
|
Direct |
2,656
+3.18%
|
-
|
|
Aug 15
2024
|
Eric D. Shaff CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,813
+5.0%
|
-
|
|
Aug 15
2024
|
David S. Ege |
BUY
Exercise of conversion of derivative security
|
Direct |
2,969
+3.64%
|
-
|
|
Aug 05
2024
|
Teresa L. Young |
SELL
Open market or private sale
|
Direct |
24,480
-23.85%
|
$24,480
$1.08 P/Share
|
|
Aug 03
2024
|
Teresa L. Young |
BUY
Exercise of conversion of derivative security
|
Direct |
85,000
+45.3%
|
-
|